MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting ...

Annual Biotechnology, Systems, and Synthetic Biology Poster Fair: This event will be held in the Spring Quarter at a venue located at the Chicago campus, at which students and postdocs will have the ...

(NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted ...

PanGIA Biotech Announces Upcoming ASCO 2025 Poster Presentation of Collaborative Research. PanGIA Biotech, a company advancing urine-based, AI-driven diagnostics for early cancer detection, today ...

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics Contacts Investor Relations Contact +1 (872) 270-3518 ir ...

Biotechnology articles from across Nature Portfolio. ... New tools and products developed by biotechnologists are useful in research, agriculture, industry and the clinic. Featured.

MAIA Biotechnology, Inc.,, ... that a late-breaking abstract detailing new updates from its Phase 2 THIO-101 clinical trial was selected for oral and poster ... a category reserved for research ...

CHICAGO, October 15, 2024--MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics ...

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics Oct. 15, 2024 8:15 AM ET MAIA Biotechnology, Inc. (MAIA) ...